A citation-based method for searching scientific literature

Xinyan Xie, Li Li, Hao Wu, Fang Hou, Yanlin Chen, Qi Xue, Yu Zhou, Jiajia Zhang, Jianhua Gong, Ranran Song. Autism Res 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A novel fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis.
Jiaoyang Cai, Xia Huang, Minzhi Yin, Ci Pan, Lili Song, Zhiyan Zhan, Jing Chen, Yijin Gao, Jingyan Tang, Yanxin Li,[...]. Int J Cancer 2019
8
50

Winchester syndrome: the progression of radiological findings over a 23-year period.
Radovan Vanatka, Cécile Rouzier, Jean Claude Lambert, Carole Leroux, Alain Coussement. Skeletal Radiol 2011
8
50

Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
Jing Lian, Li-Xia Wang, Jiang-Hong Guo, Peng Bu, Yan-Feng Xi, Ke-Ming Yun. Diagn Pathol 2021
4
50

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.
Tingting Jiang, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen, Liang Ouyang. Acta Pharm Sin B 2021
41
50

Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.
Jason Y K Chan, Peony Hiu Yan Poon, Yong Zhang, Cherrie W K Ng, Wen Ying Piao, Meng Ma, Kevin Y Yip, Amy B W Chan, Vivian Wai Yan Lui. F1000Res 2018
8
50

EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition.
Takayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, Hiromichi Ebi, Takako Sano, Shigeki Nanjo, Daisuke Ishikawa, Mitsuo Sato, Yoshinori Hasegawa, Yoshitaka Sekido,[...]. Cancer Res 2013
134
50

Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
Yirong Sim, Veronique K M Tan, Nur A B Sidek, Daryl K A Chia, Benita K T Tan, Preetha Madhukumar, Wei Sean Yong, Chow Yin Wong, Kong Wee Ong. ANZ J Surg 2018
7
50

Synchronous Bilateral Breast Cancers.
Naveen Padmanabhan, Annapurneswari Subramanyan, Selvi Radhakrishna. J Clin Diagn Res 2015
15
50

Mammary Analogue Secretory Carcinoma.
Vishwas Parekh, Todd M Stevens. Arch Pathol Lab Med 2016
31
50

Integrated Multi-Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal-Like Triple-Negative Breast Cancer.
Min-Sun Jin, Hyebin Lee, Jongmin Woo, Seongmin Choi, Mi Sol Do, Kwangsoo Kim, Min Ji Song, Youngsoo Kim, In Ae Park, Dohyun Han,[...]. Proteomics Clin Appl 2018
11
50

Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Marick Laé, Paul Fréneaux, Xavier Sastre-Garau, Olfa Chouchane, Brigitte Sigal-Zafrani, Anne Vincent-Salomon. Mod Pathol 2009
119
50


Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.
David P Horowitz, Charu S Sharma, Eileen Connolly, Daniela Gidea-Addeo, Israel Deutsch. Breast 2012
65
50

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
Cristina Tognon, Stevan R Knezevich, David Huntsman, Calvin D Roskelley, Natalya Melnyk, Joan A Mathers, Laurence Becker, Fatima Carneiro, Nicol MacPherson, Doug Horsman,[...]. Cancer Cell 2002
611
50

Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry.
Raihanatou Diallo, Karl-Ludwig Schaefer, Agnes Bankfalvi, Thomas Decker, Monika Ruhnke, Pia Wülfing, Christian Jackisch, Jutta Luttges, Poul H B Sorensen, Meenakshi Singh,[...]. Hum Pathol 2003
61
50

Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
Gregor Krings, Nancy M Joseph, Gregory R Bean, David Solomon, Courtney Onodera, Eric Talevich, Iwei Yeh, James P Grenert, Elizabeth Hosfield, Emily D Crawford,[...]. Mod Pathol 2017
42
50

Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review.
Hongping Tang, Lihua Zhong, Hongbing Jiang, Yan Zhang, Guannan Liang, Guoyan Chen, Gui'e Xie. Diagn Pathol 2021
5
50

Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers.
Xiang Jiao, Laura D Wood, Monica Lindman, Sian Jones, Phillip Buckhaults, Kornelia Polyak, Saraswati Sukumar, Hannah Carter, Dewey Kim, Rachel Karchin,[...]. Genes Chromosomes Cancer 2012
57
50

Human somatic cell mutagenesis creates genetically tractable sarcomas.
Sam D Molyneux, Paul D Waterhouse, Dawne Shelton, Yang W Shao, Christopher M Watling, Qing-Lian Tang, Isaac S Harris, Brendan C Dickson, Pirashaanthy Tharmapalan, Geir K Sandve,[...]. Nat Genet 2014
23
50

Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma.
Neerav Shukla, Stephen S Roberts, Mollah O Baki, Qazi Mushtaq, Paul E Goss, Ben H Park, Gunes Gundem, Ken Tian, Heather Geiger, Kristie Redfield,[...]. JCO Precis Oncol 2017
36
50

Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast.
Piguo Gong, Chen Xia, Yifeng Yang, Wang Lei, Weiping Yang, Junhua Yu, Yishun Ji, Lijun Ren, Fugui Ye. Sci Rep 2021
5
50

Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential.
Raza S Hoda, Edi Brogi, Fresia Pareja, Gouri Nanjangud, Melissa P Murray, Britta Weigelt, Jorge S Reis-Filho, Hannah Y Wen. Histopathology 2019
29
50

Gene expression profiles for low-dose exposure to diethyl phthalate in rodents and humans: a translational study with implications for breast carcinogenesis.
Kalpana Gopalakrishnan, Vasily N Aushev, Fabiana Manservisi, Laura Falcioni, Simona Panzacchi, Fiorella Belpoggi, Humberto Parada, Gail Garbowski, Hanina Hibshoosh, Regina M Santella,[...]. Sci Rep 2020
12
50

Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study.
Scott M Langevin, Devin C Koestler, Brock C Christensen, Rondi A Butler, John K Wiencke, Heather H Nelson, E Andres Houseman, Carmen J Marsit, Karl T Kelsey. Epigenetics 2012
66
50

Clinical and mutation profile of multicentric osteolysis nodulosis and arthropathy.
Gandham SriLakshmi Bhavani, Hitesh Shah, Anju Shukla, Neerja Gupta, Kalpana Gowrishankar, Anand P Rao, Madhulika Kabra, Meenal Agarwal, Prajnya Ranganath, Alka V Ekbote,[...]. Am J Med Genet A 2016
19
50

The landscape of genetic aberrations in myxofibrosarcoma.
Yasuhide Takeuchi, Kenichi Yoshida, Adriane Halik, Annegret Kunitz, Hiromichi Suzuki, Nobuyuki Kakiuchi, Yusuke Shiozawa, Akira Yokoyama, Yoshikage Inoue, Tomonori Hirano,[...]. Int J Cancer 2022
5
50

Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base.
John Doromal Jacob, Caitlin Hodge, Jan Franko, Christopher M Pezzi, Charles D Goldman, Vicki Suzanne Klimberg. J Surg Oncol 2016
26
50


c-myc amplification in ovarian cancer.
V V Baker, M P Borst, D Dixon, K D Hatch, H M Shingleton, D Miller. Gynecol Oncol 1990
119
50

Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma.
Annette Staebler, Bianca Karberg, Juliane Behm, Petra Kuhlmann, Ulrike Neubert, Hartmut Schmidt, Eberhard Korsching, Horst Bürger, Ralph Lelle, Ludwig Kiesel,[...]. Genes Chromosomes Cancer 2006
24
50

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.
Da Wei Huang, Brad T Sherman, Richard A Lempicki. Nucleic Acids Res 2009
50

An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.
Joan P Breyer, Daniel C Dorset, Travis A Clark, Kevin M Bradley, Tiina A Wahlfors, Kate M McReynolds, William H Maynard, Sam S Chang, Michael S Cookson, Joseph A Smith,[...]. Am J Hum Genet 2014
21
50

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13.
Mei Zeng, Nicholas P Kwiatkowski, Tinghu Zhang, Behnam Nabet, Mousheng Xu, Yanke Liang, Chunshan Quan, Jinhua Wang, Mingfeng Hao, Sangeetha Palakurthi,[...]. Elife 2018
80
50

PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
Hiroyuki Okamoto, Kohichiroh Yasui, Chen Zhao, Shigeki Arii, Johji Inazawa. Hepatology 2003
92
50

PVT1 dependence in cancer with MYC copy-number increase.
Yuen-Yi Tseng, Branden S Moriarity, Wuming Gong, Ryutaro Akiyama, Ashutosh Tiwari, Hiroko Kawakami, Peter Ronning, Brian Reuland, Kacey Guenther, Thomas C Beadnell,[...]. Nature 2014
518
50

8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
Gaelle Fromont, Julie Godet, Antoine Peyret, Jacques Irani, Olivier Celhay, François Rozet, Xavier Cathelineau, Olivier Cussenot. Hum Pathol 2013
55
50

PRL-3 facilitates Hepatocellular Carcinoma progression by co-amplifying with and activating FAK.
Qiming Zhou, Qianlei Zhou, Qinghua Liu, Zhanghai He, Yongcong Yan, Jianhong Lin, Zheng Chen, Chuanchao He, Kai Mao, Jie Wang,[...]. Theranostics 2020
6
50


MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.
Yicun Wang, Xin Li, Wei Liu, Bingjin Li, Dongquan Chen, Fengping Hu, Lizhong Wang, Xiaoguang M Liu, Ranji Cui, Runhua Liu. Oncogene 2019
29
50

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
Da Wei Huang, Brad T Sherman, Richard A Lempicki. Nat Protoc 2009
50

High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors.
Peter M Haverty, Lawrence S Hon, Joshua S Kaminker, John Chant, Zemin Zhang. BMC Med Genomics 2009
78
50

DEPTOR at the Nexus of Cancer, Metabolism, and Immunity.
Alexandre Caron, David M Briscoe, Denis Richard, Mathieu Laplante. Physiol Rev 2018
51
50

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.
Maria B Raeder, Even Birkeland, Jone Trovik, Camilla Krakstad, Shyemaa Shehata, Steven Schumacher, Travis I Zack, Antje Krohn, Henrica Mj Werner, Susan E Moody,[...]. PLoS One 2013
65
50


Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
David D Bowtell, Steffen Böhm, Ahmed A Ahmed, Paul-Joseph Aspuria, Robert C Bast, Valerie Beral, Jonathan S Berek, Michael J Birrer, Sarah Blagden, Michael A Bookman,[...]. Nat Rev Cancer 2015
632
50


Evolution of pogo, a separate superfamily of IS630-Tc1-mariner transposons, revealing recurrent domestication events in vertebrates.
Bo Gao, Yali Wang, Mohamed Diaby, Wencheng Zong, Dan Shen, Saisai Wang, Cai Chen, Xiaoyan Wang, Chengyi Song. Mob DNA 2020
20
50

Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling.
Yonggang Zhang, Shu Liu, Hong Wang, Wensheng Yang, Fang Li, Fan Yang, Daohai Yu, Frederick V Ramsey, George P Tuszyski, Wenhui Hu. Oncotarget 2015
19
50

c-MYC and Epithelial Ovarian Cancer.
Jeyshka M Reyes-González, Pablo E Vivas-Mejía. Front Oncol 2021
14
50

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.
Dariush Etemadmoghadam, Anna deFazio, Rameen Beroukhim, Craig Mermel, Joshy George, Gad Getz, Richard Tothill, Aikou Okamoto, Maria B Raeder, Paul Harnett,[...]. Clin Cancer Res 2009
207
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.